Stada Arz takes a leading position in the third Barmer GEK discount round

German branded and generic drugmaker Stada Arzneimittel (SAZ: GR) says that its sales companies have taken a leading position in the third tender for discount agreements with Barmer GEK, the largest public health insurance organization in Germany.

They were able to secure 12 exclusive and seven multiple awards. The total tender volume came to around 382 million euros ($502.2 million) according to the insurance. The contracts take effect in November 2012 and apply for 8.7 million insured persons.

“With this success, the Stada Group has once again proven its strong position and efficiency in the challenging environment of German discount agreements,” says Hartmut Retzlaff, chairman of the executive board, adding: “With a view to the successful results of recent discount agreement rounds, we are confident that we will be able to further expand our share of the German generics market.”